MosaiQ AiPlex® Vasculitis assay now available for clinical use in the European Union and other CE mark accepting countries
AliveDx achieves IVDR-CE Mark for a multiplexed MosaiQ AiPlex® Vasculitis (VAS) assay, designed to advance the testing of Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides and Anti-GBM(Goodpasture's) disease and improve time to results to support diagnosis of autoimmune vasculitis. ...